ArticleFEBS open bio2026
Identification and characterization of a gene conferring stress resistance in Escherichia coli and cyanobacteria.
Article in FEBS open bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Picosynechococcus sp. strain NKBG15041c is a cyanobacterium isolated from the ocean and while it is known for rapid growth, the basis of its high proliferation capacity remains unclear. Screening for genes which may underlie this rapid growth using E. coli, we identified a gene that promotes growth and enhances stress resistance. The protein encoded by this gene (PcSyn14890) is specific to cyanobacteria, and no homologs with known functions have been identified. In P. NKBG15041c, expression of this gene was induced during the early stage of growth and when introduced into a different cyanobacterium, the transformants exhibited accelerated growth, enhanced stress resistance, and increased ATP and Chlorophyll a content. We hypothesized that PcSyn14890 functions as an ATP-independent chaperone. To investigate further, recombinant PcSyn14890 was expressed in E. coli, purified, and subjected to structural and functional characterization. PcSyn14890 existed as monomers or dimers and did not form higher-order oligomers. Its small-angle X-ray scattering profile was consistent with the AlphaFold3 predicted structure, and the CD spectrum confirmed its β-sheet-rich composition. However, contrary to expectations, PcSyn14890 was unable to prevent the thermal aggregation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Thus, we conclude that PcSyn14890 does not function as a general molecular chaperone and therefore the mechanism by which expression of PcSyn14890 enhances the stress tolerance of E. coli and S. PCC6803 requires further investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.